Global Vaccine Growth Opportunities
Frost & Sullivan provides an outlook for the global vaccine industry for 2022 and beyond, including emerging trends and growth opportunities. Innovation, which remains mainstream in vaccine development, is augmenting investments by emerging vaccine developers in designing novel technology platforms, especially for nucleic acid-based vaccines. Spurred by the ongoing pandemic, vaccine developers have accelerated the pace of transformation, and the concepts of manufacturing decentralization, digitization of supply-chain, and increased outsourcing have taken center stage. Moreover, companies entering into public-private-partnerships to capitalize on the current situation are likely to establish synergistic relationships at all levels.
The new vision in 2022 is focused on government authorities having several shifts in vaccine development programs and reaching “zero-dose” children to attain vaccination equity in emerging economies. The tailored and targeted approach used by logistics companies for individual vaccines is providing catalytic support to vendors in the vaccine industry. The adoption of innovative technologies and supply-chain resilience by manufacturers to improve their strategic position in the global vaccine market, while ensuring the accessibility of vaccines remains outcome-based in countries with unmet needs, is a prominently emerging business model. The rising focus on prophylactic management of COVID-19 in 2021-2022 is anticipated to shift toward novel delivery modes of traditional vaccines and on highly prevalent disease areas, such as RSV, HIV, and cancer. Technology transfer is crucial for outsourcing to CDMOs, and the shift toward the development of patient-centric models for vaccine delivery is paramount.
RESEARCH HIGHLIGHTS
Traditional and COVID-19 vaccine market size, including key segments from 2022 to 2027
Dynamics around COVID-19 vaccination and the path to endemicity
Role of advancements, such as decentralization, technologies, and new modalities, in driving the vaccine value-chain transformation
The current and future R&D and investment outlook, and its evolution
Strategic time-defined growth opportunities for ecosystem participants to focus on in the near future
- Strategic Imperatives
- Why is it Increasingly Difficult to Grow?
- The Strategic Imperative 8™
- Top Three Strategic Imperatives in the Global Vaccines Industry
- Growth Opportunities Fuel the Growth Pipeline Engine™
- Vaccine Landscape—Key Takeaways
- Growth Opportunity Matrix
- Growth Opportunity Analysis, Vaccines
- Scope of Analysis
- Vaccines—Introduction and Segmentation
- Definitions—By Production System
- Definitions—By Technology Type
- Growth Drivers for Vaccines Market
- Growth Restraints for Vaccines Market
- Growth Environment
- Vaccine Coverage Rate
- Areas of Unmet Vaccine Needs
- Government Initiatives in Vaccines Industry, 2021
- Vaccine Developers Landscape
- Pipeline Snapshot, COVID-19 Vaccines
- Pipeline Snapshot, Vaccines, 2021
- Vaccines Supply Chain—Key Stakeholders
- Vaccines Value Chain—The Expanding Role of Different Stakeholders
- Vaccines Distribution Framework
- Vaccines Distribution Scenario
- Evolving Vaccine Delivery Model—Private Sector Fortifying Distribution
- Increasing Role of Digital Technology in Vaccines Supply Chain
- Key Partnerships and Collaborations, Traditional Vaccines, 2020–2022
- Key Partnerships and Collaborations, COVID-19 Vaccines, 2020–2022
- Key Manufacturing Partnerships With Bio-CDMOs for Approved COVID-19 Vaccines—US
- Key Manufacturing Partnerships With Bio-CDMOs for Approved COVID-19 Vaccines—Europe
- Key Strategies in the Vaccine Industry
- Technological Advancements in Vaccines Industry
- Growth Opportunity Analysis, Traditional Vaccines
- Key Growth Metrics for Traditional Vaccines
- Research Methodology
- Forecast Assumptions
- Revenue Forecast
- Table Traditional Vaccines: Revenue Forecast, Global, 2021–2027
- Revenue Forecast Analysis
- Revenue Forecast by Technology Type
- Table Traditional Vaccines: Revenue Forecast by Technology Type, Global, 2021–2027
- Percent Revenue Forecast by Technology Type
- Revenue by Production System
- Percent Revenue by Region
- Competitive Environment
- Market Share Analysis
- Growth Opportunity Analysis, COVID-19 Vaccines
- Key Growth Metrics
- Research Methodology
- Forecast Assumptions
- Revenue Forecast
- Revenue Forecast Analysis
- Revenue by Technology Type
- Revenue by Production System
- Percent Revenue by Region
- Competitive Environment
- Market Share Analysis
- Companies to Watch
- Companies to Watch From 2022–2027
- Growth Opportunity Universe, Vaccines
- Growth Opportunity 1—Building Capabilities for the Development of Nucleic Acid-based Vaccines for Cancer and HIV
- Promising Key Nucleic Acid-based Vaccines in the Pipeline
- Growth Opportunity 2—Pediatric Combination Vaccines for Highly Prevalent Infectious Diseases
- Mitigation Measures for Combination Vaccines
- Growth Opportunity 3—Tech Transfer in Emerging Economies to Boost the Production Efficiency and Pace
- Growth Opportunity 4—Developing Countries Entering Into Licensing and Joint Ventures to Build Domestic Capabilities
- Growth Opportunity 5—Exploring New Disease Areas to Meet the Growing Need for Immunization
- Next Steps
- Your Next Steps
- Why Frost, Why Now?
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook